The revised NIH Public Access Policy (available here), revised in April 2025, requires that all manuscripts accepted for publication on or after July 1, 2025, be submitted to PubMed Central (PMC; a digital archive of full-text biomedical and life sciences journal literature) upon acceptance for publication, to be made publicly available without embargo by the publishing journal.
The policy also requires a statement in the work acknowledging federal funding and communicating rights (see NIH Rights Statement) The NIH provides the following sample language:
“This work is the result of NIH funding, in whole or in part, and is subject to the NIH Public Access Policy. Through acceptance of this federal funding, the NIH has been given a right to make the work publicly available in PubMed Central.”
Note: This new policy supersedes the 2008 NIH Public Access Policy (applicable to manuscripts accepted before July 1, 2025) requiring that NIH-supported researchers submit final peer-reviewed manuscripts to PMC upon acceptance for publication, to be made freely available to the public after an allowable embargo period of not more than 12 months after the official date of publication.
Journal compliance
The ASCI (publisher of the Journal) is in compliance with the revised NIH Public Access Policy. The Journal submits the final published version of the article on the author’s behalf with no embargo. The NIH considers this to be provisionally compliant until a PMCID is issued, and authors are not expected to take additional steps.